Thomas Tom C

See RemarksVincerx Pharma, Inc. (VINC) · full profile →Form 4 · filed Aug 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2024Disposed to issuer(D)55K0
Aug 12, 2024Grant(A)55K55K
Aug 12, 2024Disposed to issuer(D)58K0
Aug 12, 2024Grant(A)58K58K
Aug 12, 2024Disposed to issuer(D)56K0
Aug 12, 2024Grant(A)56K56K
Aug 12, 2024Grant(A)175K175K
Aug 12, 2024Grant(A)86K86K
Aug 12, 2024Disposed to issuer(D)94K0
Aug 12, 2024Grant(A)94K94K
Aug 12, 2024Disposed to issuer(D)31K0
Aug 12, 2024Grant(A)31K125K
Aug 12, 2024Disposed to issuer(D)175K0
Aug 12, 2024Disposed to issuer(D)86K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-097330) within minutes of acceptance. Every field above traces to the original document. Verify it directly: